Orchard Therapeutics at Cell 2026

Nov 12–13, 2026 London, UK ~800 attendees Website

Orchard Therapeutics takes part in 2 sessions at Cell 2026 in London, its home city. Its sessions cover building a viable business model for cell and gene therapies and automating their manufacture. The specific focus is automating gene therapies made from a patient's own blood-forming stem cells.

OrganizationCell 2026 Attendance
Biotech
Kyowa Kirin company developing and marketing haematopoietic stem cell gene therapies for rare diseases.
Panel
Fri Nov 13
9:25am–9:50am
Talk
Fri Nov 13
5:30pm–5:55pm
Automation Of Autologous HSC Gene Therapies
Cell and gene therapyManufacturing and CMC

Explore the full Cell 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in London. Leave your work email and we’ll be in touch.

Privacy

Download the full Cell 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Orchard Therapeutics

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by Cell 2026 or its organizers. Submit a correction